Guess Who Picked Americas Carmart Inc. (NASDAQ:CRMT) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Americas Carmart Inc. (NASDAQ:CRMT) reported that Magnolia Capital Fund, Lp has picked up 426,421 of common stock as of 2017-03-29.
The acquisition brings the aggregate amount owned by Magnolia Capital Fund, Lp to a total of 426,421 representing less than 5.5% stake in the company.
For those not familiar with the company, America’s Car-Mart, Inc. is an automotive retailer focused on the integrated auto sales and finance segment of the used car market. The Company conducts its operations through its two operating subsidiaries, America’s Car Mart, Inc. (Car-Mart of Arkansas) and Colonial Auto Finance, Inc. (Colonial) (Collectively, Car-Mart of Arkansas and Colonial are referred to as Car-Mart). It primarily sells older model used vehicles and provides financing for all of its customers. As of April 30, 2016, the Company operated 143 dealerships located primarily in small cities throughout the South-Central United States. Dealerships are operated on a decentralized basis. Each dealership is responsible for buying (with the assistance of a corporate office buyer) and selling vehicles, making credit decisions, and servicing and collecting the installment contracts it originates. Dealerships also maintain their own records and make daily deposits. The Company has both regular and satellite dealerships.
A glance at Americas Carmart Inc. (NASDAQ:CRMT)’s key stats reveals a current market capitalization of 267.91 Million based on 7.80 Million shares outstanding and a price at last close of $35.05 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-05-24, Von picked up 2,000 at a purchase price of $21.33. This brings their total holding to 10,000 as of the date of the filing.
On the sell side, the most recent transaction saw Henderson unload 10,000 shares at a sale price of $41.65. This brings their total holding to 76,984.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Americas Carmart Inc. (NASDAQ:CRMT) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Broadfin Capital Picked Up Alphatec Holdings Inc. (NASDAQ:ATEC) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Alphatec Holdings Inc. (NASDAQ:ATEC) reported that has picked up 1,164,618 of common stock as of 2017-03-29.
The acquisition brings the aggregate amount owned by Broadfin Capital to a total of 1,164,618 representing less than 9.99% stake in the company.
For those not familiar with the company, Alphatec Holdings, Inc. is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc. and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures. Its products include Cervical and Cervico-Thoracic Products, which include Trestle Luxe Anterior Cervical Plate System and Pegasus Anchored Cervical Interbody; Thoracolumbar Fixation Products, which include Arsenal Degenerative System and OsseoScrew Spinal Fixation System; Spinal Spacers, which include Battalion Universal Spacer System and Alphatec Solus Locking ALIF Spinal Spacer; minimally invasive surgery Products, which include Illico Minimally Invasive Surgery System and BridgePoint Spinous Process Fixation System, and Biologics, which include Neocore Osteoconductive Matrix.
A glance at Alphatec Holdings Inc. (NASDAQ:ATEC)’s key stats reveals a current market capitalization of 21.89 Million based on 8.81 Million shares outstanding and a price at last close of $2.40 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-12-16, Cross picked up 15,000 at a purchase price of $4.25. This brings their total holding to 65,443 as of the date of the filing.
On the sell side, the most recent transaction saw Foster unload 1,033 shares at a sale price of $5.25. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Alphatec Holdings Inc. (NASDAQ:ATEC) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
5am Ventures Llc. is Buying Pulmatrix Inc. (NASDAQ:PULM) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Pulmatrix Inc. (NASDAQ:PULM) reported that 5am Ventures Llc. has picked up 251,188 of common stock as of 2017-03-29.
The acquisition brings the aggregate amount owned by 5am Ventures Llc. to a total of 251,188 representing less than 1.41% stake in the company.
For those not familiar with the company, Pulmatrix, Inc. is a clinical stage biopharmaceutical company developing inhaled therapies to address serious pulmonary disease. The Company’s product pipeline is focused on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with lung disease, including cystic fibrosis. In addition, the Company focuses on pulmonary diseases through collaboration with partners, including PUR0200, a generic in clinical development for chronic obstructive pulmonary disease.
A glance at Pulmatrix Inc. (NASDAQ:PULM)’s key stats reveals a current market capitalization of 53.11 Million based on 17.83 Million shares outstanding and a price at last close of $3.23 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-06-15, Mcguire picked up 1,392 at a purchase price of $6.88. This brings their total holding to 52,722 as of the date of the filing.
On the sell side, the most recent transaction saw Oculus unload 922,500 shares at a sale price of $2.75. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Pulmatrix Inc. (NASDAQ:PULM) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Up Si Financial Group Inc. (NASDAQ:SIFI) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Si Financial Group Inc. (NASDAQ:SIFI) reported that Clover Partners, L.p. has picked up 617,773 of common stock as of 2017-03-29.
The acquisition brings the aggregate amount owned by Clover Partners, L.p. to a total of 617,773 representing less than 5.1% stake in the company.
For those not familiar with the company, SI Financial Group, Inc. is a holding company for Savings Institute Bank and Trust Company (the Bank). The Bank operates as a community-oriented financial institution offering a range of financial services to consumers and businesses in its market area, including insurance, trust and investment services. The Bank accepts deposits from the general public and uses those funds to originate one- to four-family residential mortgage loans, multi-family and commercial real estate loans, commercial business loans, and construction and consumer loans. The Bank also purchases commercial business loans, including loans fully guaranteed by the Small Business Administration (SBA) and the United States Department of Agriculture (USDA). The Bank sells certain fixed-rate one- to four-family residential conforming loans it originates in the secondary market with the servicing retained. The remainder of the Bank’s loan portfolio is originated for investment.
A glance at Si Financial Group Inc. (NASDAQ:SIFI)’s key stats reveals a current market capitalization of 164.17 Million based on 12.20 Million shares outstanding and a price at last close of $13.55 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2014-12-08, Engle picked up 500 at a purchase price of $11.22. This brings their total holding to 9,907 as of the date of the filing.
On the sell side, the most recent transaction saw Gervais unload 5,379 shares at a sale price of $11.26. This brings their total holding to 14,657.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Si Financial Group Inc. (NASDAQ:SIFI) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up Homefed Corp (OTCMKTS:HOFD) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Homefed Corp (OTCMKTS:HOFD) reported that Cumming Ian M. has picked up 2,500 of common stock as of 2017-03-29.
The acquisition brings the aggregate amount owned by Cumming Ian M. to a total of 2,500 representing less than 0.1% stake in the company.
For those not familiar with the company, HomeFed Corporation is a developer and owner of residential and mixed-use real estate projects in California, Virginia, South Carolina, Florida, Maine and New York. The Company operates through three segments: real estate, farming and corporate. Its real estate operations consist of a range of residential and commercial land development projects and other unimproved land, all in various stages of development, and retail and office operating properties. Real estate also includes the equity method investments in Brooklyn Renaissance Holding Company LLC (BRP Holding) and Brooklyn Renaissance Hotel LLC (BRP Hotel). Its farming operations consist of the Rampage property, which includes an operating grape vineyard. The Company, as the owner of development projects, is engaged in a range of activities, including design engineering, grading raw land, constructing public infrastructure and finishing individual lots for home sites or other facilities.
A glance at Homefed Corp (OTCMKTS:HOFD)’s key stats reveals a current market capitalization of 682.82 Million based on 15.45 Million shares outstanding and a price at last close of $44.20 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-03-23, Leucadia picked up 783,889 at a purchase price of $39.95. This brings their total holding to 10,838,115 as of the date of the filing.
On the sell side, the most recent transaction saw Cumming unload 65,704 shares at a sale price of $39.95. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Homefed Corp (OTCMKTS:HOFD) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Blue Capital Reinsurance Holdings Ltd. (NYSE:BCRH) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Blue Capital Reinsurance Holdings Ltd. (NYSE:BCRH) reported that Sompo Holdings, Inc. has picked up 2,911,518 of common stock as of 2017-03-29.
The acquisition brings the aggregate amount owned by Sompo Holdings, Inc. to a total of 2,911,518 representing a 33.3% stake in the company.
For those not familiar with the company, Blue Capital Reinsurance Holdings Ltd. provides collateralized reinsurance in the property catastrophe market and invests in various insurance-linked securities. The Company conducts its operations through its subsidiaries, including Blue Capital Re Ltd. (Blue Capital Re), which provides collateralized reinsurance, and Blue Capital Re ILS Ltd. (Blue Capital Re ILS), which conducts hedging and other investment activities. Blue Capital Re provides reinsurance to third-party insurance and reinsurance companies through reinsurance contracts, either directly with the cedant or on a fronted basis. Blue Capital Re ILS may purchase catastrophe bonds to access certain risks. Blue Capital Re or Blue Capital Re ILS may buy and sell industry loss warranties as a way to access certain risks. Blue Capital Re ILS’ portfolio may include over-the-counter or exchange-traded futures or options listed on catastrophe indexes, such as catastrophe or weather derivatives.
A glance at Blue Capital Reinsurance Holdings Ltd. (NYSE:BCRH)’s key stats reveals a current market capitalization of 163.74 Million based on 8.76 Million shares outstanding and a price at last close of $18.65 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-02-08, Weale picked up 2,800 at a purchase price of $17.78. This brings their total holding to 3,267 as of the date of the filing.
On the sell side, the most recent transaction saw Montpelier unload 51,000 shares at a sale price of $20.00. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Blue Capital Reinsurance Holdings Ltd. (NYSE:BCRH) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Imprimis Pharmaceuticals Inc. (NASDAQ:IMMY) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Imprimis Pharmaceuticals Inc. (NASDAQ:IMMY) reported that Longboard Capital Advisors, Llc. has picked up 1,312,000 of common stock as of 2017-03-29.
The acquisition brings the aggregate amount owned by Longboard Capital Advisors, Llc. to a total of 1,312,000 representing a 6.58% stake in the company.
For those not familiar with the company, Imprimis Pharmaceuticals, Inc. (Imprimis) is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. The Company, through its Imprimis Cares program, owns, markets and dispenses a portfolio of compounded therapeutic in several therapeutic areas, including ophthalmology, urology, otolaryngology and infectious diseases. The Company is also developing Custom Compounding Choice business, which is focused on developing and dispensing a portfolio of non-proprietary compounded drugs for humans and animals in therapeutic areas that may be overlooked by commercial pharmaceutical companies. The Company also offers customizable compounding products that consist of sterile injectable and non-sterile integrative medicine therapies that are used in various therapeutic areas.
A glance at Imprimis Pharmaceuticals Inc. (NASDAQ:IMMY)’s key stats reveals a current market capitalization of 85.48 Million based on 19.94 Million shares outstanding and a price at last close of $3.85 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-12-19, Lindstrom picked up 100,000 at a purchase price of $1.79. This brings their total holding to 100,000 as of the date of the filing.
On the sell side, the most recent transaction saw Miloni unload 110,000 shares at a sale price of $8.00. This brings their total holding to 468,576.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Imprimis Pharmaceuticals Inc. (NASDAQ:IMMY) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Rosalind Advisors, Inc. Picked Zosano Pharma Corp (NASDAQ:ZSAN) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Zosano Pharma Corp (NASDAQ:ZSAN) reported that Rosalind Advisors, Inc. has picked up 2,083,100 of common stock as of 2017-03-29.
The acquisition brings the aggregate amount owned by Rosalind Advisors, Inc. to a total of 2,083,100 representing a 5.5% stake in the company.
For those not familiar with the company, Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability. The Company’s short-wear-time transdermal patch consists of an array of titanium microneedles that is coated with its formulation of an approved drug and attached to an adhesive patch. When the patch is applied with its hand-held applicator, the microneedles painlessly penetrate the skin, resulting in rapid dissolution and absorption of the drug coating through the capillary bed. Its product candidates include ZP-Triptan, ZP-Glucagon and ZP-PTH. ZP-PTH is a formulation of teriparatide, a synthetic form of parathyroid hormone. ZP-Glucagon is a formulation of glucagon.
A glance at Zosano Pharma Corp (NASDAQ:ZSAN)’s key stats reveals a current market capitalization of 62.47 Million based on 33.82 Million shares outstanding and a price at last close of $1.88 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-08-19, Erbez picked up 47,750 at a purchase price of $1.32. This brings their total holding to 47,750 as of the date of the filing.
On the sell side, the most recent transaction saw Barrett unload 1,099,996 shares at a sale price of $2.01. This brings their total holding to 952,809.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Zosano Pharma Corp (NASDAQ:ZSAN) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.